You are here

Small Molecules

Search our small molecule opportunities against novel cancer targets and pathways. We have drug discovery, pre-clinical and clinical stage opportunities available for co-development and/or licensing.

CRT is seeking a co-development or licensing partner to take this Clinical Development Candidate into Phase I clinical studies.

Read more

CRT is seeking a co-development or licensing partner to drive candidate selection and entry into formal pre-clinical studies.

Read more

Small Molecules - In Vivo Proof of Principle

Read more

Cancer Research Technology is offering prospective commercial partners global therapeutic rights to the FLT3-FAK-VEGFR3 triple kinase inhibitor programme on an exclusive basis.

Read more

CRT is seeking a commercial partner interested in pursuing a co-development or direct licensing arrangement.

Read more

Pages